The Guard Control Trial - Randomized, Controlled, Muti-centric, Clinical Study to Assess Whether Type 1 Diabetic Patients in Poor Glycemic Control Can Improve Using the Real-time Values of the Guardian RT Versus Conventional Self-Monitoring Blood Glucose
Sponsor study identifier
interventional
156
7 countries
8
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2005
Actual (reported)Study Completion
June 2005
Actual (reported)The purpose of this study is to determine whether Type 1 diabetic patients using the Guardian RT glucose sensor can improve glycemic control over a 12-week period, compared to patients using self-monitoring blood glucose testing (SMBG) alone.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2005
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
June 2005
Actual (reported)June 2005
Actual (reported)April 5, 2011
Actual (reported)April 8, 2011
Actual (reported)Difference in Change in A1c (%) between continuous use of CGM and control
12 weeks
Difference in change in A1c (%) between biweekly use of CGM and control
12 weeks
Difference in change in A1c (%) between biweekly use of CGM and continuous use of CGM
12 weeks
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hospital Sud Francilien
Corbeil-Essonnes, France
CH Robert Debre
Paris, France
Klinik fur Allgemeine Charite
Berlin, Germany
Schneider Children Centre
Petah Tikva, Israel
U.O. Medicina Generale
Milan, Italy
University Children's Hospital
Ljubljana, Slovenia
Huddinge University Hospital
Huddinge, Sweden
156 participants (actual enrollment reported by the registry).
First Submitted
April 5, 2011
First Posted
April 8, 2011
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
Contact the study team to confirm eligibility.
Royal Bournemouth Hospital
Dorset, United Kingdom
Primary Completion
June 2005
Actual (reported)Study Completion
June 2005
Actual (reported)Last Updated
April 18, 2011
Record last verified: 2011-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: